FITC-Ahx-Gly-Arg-Gly-Asp-Ser-Pro

FITC-Ahx Gly Arg Gly Asp Ser Pro is a GRGDSP (HY-P0290) coupled to FITC. GRGDSP is an integrin inhibitor that can inhibit the adherence of tumor cells to endothelial cells of blood vessels and limit its metastasis[1].

Product Specifications

CAS Number

[2022956-44-9]

UNSPSC

12352209

Target

Integrin

Type

Peptides

Related Pathways

Cytoskeleton

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/fitc-ahx-gly-arg-gly-asp-ser-pro.html

Purity

98.94

Solubility

DMSO : 50 mg/mL (ultrasonic)

Smiles

O=C1OC2(C3=CC=C(O)C=C3OC4=CC(O)=CC=C42)C5=CC=C(NC(NCCCCCC(NCC(N[C@@H](CCCNC(N)=N)C(NCC(N[C@@H](CC(O)=O)C(N[C@@H](CO)C(N6[C@@H](CCC6)C(O)=O)=O)=O)=O)=O)=O)=O)=S)C=C51

Molecular Formula

C49H59N11O16S

Molecular Weight

1090.12

References & Citations

[1]Qian J, et al. Transarterial administration of integrin inhibitor loaded nanoparticles combined with transarterial chemoembolization for treating hepatocellular carcinoma in a rat model. World J Gastroenterol. 2016 Jun 7;22 (21) :5042-9.